chapter 1 Proteomics Identification of Oxidatively Modified Proteins in the Alzheimer’s Disease Brain and Models Thereof: Insights into Potential Mechanisms of Neurodegeneration -- chapter 2 Direct Evaluation of Alzheimer’s Disease-Specific Oxidative Stress with Multiphoton Microscopy -- chapter 3 Ginkgo biloba Extract and Alzheimer’s Disease: Is the Neuroprotection Explained Merely by the Antioxidant Action? -- chapter 4 Mitochondrial Nutrients: Reducing Mitochondrial Decay to Delay or Treat Cognitive Dysfunction, Alzheimer’s Disease, and Parkinson’s Disease -- chapter 5 Reactive Oxygen and Nitrogen Species: Weapons of Neuronal Destruction -- chapter 6 Amyloid-β and τ in Alzheimer’s Disease: What is the Neuropathology Trying to Tell Us? -- chapter 7 Antioxidant Therapies in the Prevention and Treatment of Alzheimer Disease -- chapter 8 F2-Isoprostanes as Biomarkers of Late Onset Alzheimer’s Disease -- chapter 9 Aspirin and Alzheimer’s Disease Protection / chapter 10 The Disposition of Lipid-Derived Carbonyls in Alzheimer’s Disease -- chapter 11 Methionine Sulfoxide Reductase System: Possible Roles in Protection against Neurodegenerative Diseases -- chapter 12 Nutritional Antioxidant Enrichment and Improved Cognitive Function in Canines -- chapter 13 Green Tea and Resveratrol as Protective Agents against Neurotoxins -- chapter 14 Oxidative Stress and AβPP Processing / chapter 15 Apple Phenolics and Alzheimer’s Disease / chapter 16 Effects of Nicotine in Models of Alzheimer’s Disease / chapter 17 The Essentiality of Iron Chelation in Neuroprotection: A Potential Role of Green Tea Catechins -- chapter 18 Ginkgo biloba Extract EGb 761 Extends Life Span and Attenuates H2O2 Levels in a Caenorhabditis elegans Model of Alzheimer’s Disease -- chapter 19 Cysteine Proteases as β-Secretases for Aβ Production in the Major Regulated Secretory Pathway of Neurons: Implications for Therapeutic Strategies in Alzheimer’s Disease -- chapter 20 The Molecular Mechanism of the Neuroprotective Action of Antioxidants Compared with the Anti-Parkinson Drug, Rasagiline -- chapter 21 Temporal Primacy of Oxidative Stress in the Pathological Cascade of Alzheimer Disease -- chapter 22 Age-Related Neuronal and Behavioral Deficits are Improved by Polyphenol-Rich Blueberry Supplementation -- chapter 23 Amyloid-β Peptide, a Therapeutic Target for Alzheimer’s Disease? -- chapter 24 Nutrition, Brain Aging, and Alzheimer’s Disease / chapter 25 Interaction between Dietary and Genetic Deficiencies in the Modulation of Homocysteine Elimination -- chapter 26 Nutriproteomics Approach to Understanding Dementia-Relevant Brain Protein Changes in Response to Grape Seed Extract, a Dietary Antioxidant.